RxDoctor Payments DataLook up a doctor →

Peter Wilcox

Gerontology · Silverdale, WANPI 1285049965

Payments from drug & device makers

$15,563in general payments, 2019–2025

Across 614 payments — averaging $25.35 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Neurocrine Biosciences, Inc.$4K
  • Amgen$1K
  • Novo Nordisk$1K
  • AstraZeneca$1K
  • Lilly USA, LLC$1K
  • Boehringer Ingelheim$861
  • plus $5K from 37 others

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Neurocrine Biosciences, Inc.14$3,935
Amgen(2 entities)73$1,496
Novo Nordisk121$1,413
AstraZeneca(2 entities)25$1,404
Lilly USA, LLC59$1,188
Boehringer Ingelheim59$861
Xeris Pharmaceuticals, Inc.26$537
Novartis23$423
Sanofi-aventis U.S. LLC22$405
Corcept Therapeutics15$401
Abbott20$371
Bayer16$365
Insulet Corporation14$277
Amphastar Pharmaceuticals, Inc.15$225
Lifescan, Inc.9$222
Tandem Diabetes Care, Inc.13$222
Radius Health, Inc.13$209
Dexcom, Inc.10$182
Recordati_rare_diseases_inc.6$155
Mannkind Corporation7$145
AbbVie6$128
Johnson & Johnson6$120
Ascensia Diabetes Care US Inc.5$108
Medtronic4$101
BETA Bionics, Inc.4$79
Kyowa Kirin, Inc.3$70
Ultragenyx Pharmaceutical Inc.2$57
Antares Pharma, Inc.3$53
Lexicon Pharmaceuticals, Inc.2$48
Amarin Pharma, Inc.3$46
EUSA Pharma (US) LLC2$45
Merck2$34
Alnylam Pharmaceuticals Inc.2$34
Insmed, Inc.1$28
Zealand Pharma US, Inc.1$25
Si-bone, Inc.1$24
Azurity Pharmaceuticals, Inc.1$24
Smith+Nephew1$20
Esperion Therapeutics, Inc.1$19
Boston Scientific1$18
Halozyme Inc1$16
Currax Pharmaceuticals LLC1$15
Cequr Corporation1$15

How this compares

$15,563 in reported general payments places this provider in the 95th percentile of 105 gerontology providers in Washington.

See all gerontology providers in Washington →

Medicare billing

Part B allowed, 2024
$312,035
Medicare patients
655
Services billed
11,957

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other gerontology in Silverdale

See the full list for Washington →

Where these figures come from

Is this you, or does something look wrong? →